Pharma News, 2018

Basel, April 9, 2018 - Novartis announced today that it has entered into an agreement and plan of merger with AveXis, Inc.

Biogen and partner Samsung Bioepis have agreed a deal that will allow their biosimilar version of AbbVie’s Humira to launch in Europe and the US.

Align Clinical CROBiopharmaceutical solutions organisation company Syneos Health has helped to establish Align Clinical CRO, a new industry standards group which aims to improve clinical trial collabo...

Regulatory reviews have started for Pfizer’s non-small cell lung cancer drug dacomitinib on both sides of the Atlantic, four years after a pair of trial failures left its future in doubt.

Ingelheim, Germany and Nantes, France – 4 April, 2018 - Boehringer Ingelheim and OSE Immunotherapeutics, a biotechnology company focused on the development of innovative immunotherapies, today annou...

European regulators have green-lighted Chiesi’s Lamzede as the first long-term enzyme replacement therapy to treat non-neurological manifestations in patients with mild to moderate alpha-mannosidosi...

Brussels, Belgium – April 05, 2018 – UCB announces the acquisition of Element Genomics, a small-size biotech spin-off from Duke University, based in Durham, North Carolina (USA).

NDIANAPOLIS, April 4, 2018 /PRNewswire/ -- Eli Lilly and Company (NYSE.

A new study reports a newly discovered link between the loss of dopamine-firing cells in the brain and the brain's ability to form new memories.

JERUSALEM, April 2 (Reuters) - Israeli drugmaker Compugen Ltd said it had agreed an exclusive licensing deal with a unit of AstraZeneca to develop antibody products to treat cancer, which coul...

The U.

Alkermes announced that it received a Refusal to File letter from the U.